Cubebin

CAS No. 1242843-00-0

Cubebin( —— )

Catalog No. M32100 CAS No. 1242843-00-0

Cubebin showes anti-inflammatory, and anticancer activities. It also shows neuroprotective effects, this could be attributed to its brain AChE inhibition and antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cubebin
  • Note
    Research use only, not for human use.
  • Brief Description
    Cubebin showes anti-inflammatory, and anticancer activities. It also shows neuroprotective effects, this could be attributed to its brain AChE inhibition and antioxidant activity.
  • Description
    Cubebin showes anti-inflammatory, and anticancer activities. It also shows neuroprotective effects, this could be attributed to its brain AChE inhibition and antioxidant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    AChE | NADH oxidase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1242843-00-0
  • Formula Weight
    356.4
  • Molecular Formula
    C20H20O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Journal of Enzyme Inhibition and Medicinal Chemistry, 01 Apr 2009, 24(2):599-606.
molnova catalog
related products
  • 8-Azabicyclo[3.2.1]o...

    8-Azabicyclo[3.2.1]octan-3-one, 8-methyl targets the MAS-related GPR member X1 (human).

  • Phenylpropiolic acid

    Phenylpropiolic acid is an endogenous metabolite.

  • 2-Deoxy-D-galactose

    2-Deoxy-D-galactose is a glucose analog and glucose antagonist that inhibits the maintenance of hippocampal LTP and can suppress tumor growth by inhibiting the glycolytic process.